Nktx stock forecast.
According to the issued ratings of 2 analysts in the last year, the consensus rating for PMV Pharmaceuticals stock is Buy based on the current 2 buy ratings for PMVP. The average twelve-month price prediction for PMV Pharmaceuticals is $10.00 with a high price target of $15.00 and a low price target of $5.00. Learn more on PMVP's analyst …
Analyst Price Forecast Suggests 852.85% Upside. As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60. The average ...Oct 18, 2023 · NKTX Stock Shows Promising Performances: Analysts Predict Significant Increase in Value NKTX stock has shown promising performances on October 18, 2023. The 8 analysts offering 12-month price forecasts for NKTX have a median target of $15.00, with a high estimate of $25.00 and a low estimate of $13.00. On August 10, 2023, Nkarta, a company listed on NASDAQ under the ticker symbol NKTX, revealed its financial performance for Nkartas Financial Report Highlights Strong Liquidity and Positive Outlook - Best StocksNkarta (NKTX) Company Description: Nkarta Inc is a bio-pharmaceutical company focused on the discovery, development and commercialization of engineered, allogeneic, and off-the-shelf cell ...
On August 10, 2023, Nkarta, a company listed on NASDAQ under the ticker symbol NKTX, revealed its financial performance for Nkartas Financial Report Highlights Strong Liquidity and Positive Outlook - Best StocksTerm Box: Best Nkarta Inc forecast, NKTX stock price prediction, NKTX forecast, Nkarta Inc finance tips, NKTX prediction, Nkarta Inc analyst report, NKTX stock price predictions 2023, Nkarta Inc stock forecast, NKTX forecast tomorrow, Nkarta Inc technical analysis, NKTX stock future price, Nkarta Inc projections, Nkarta Inc market prognosis, NKTX expected stock price.
Find the latest Evoke Pharma, Inc. (EVOK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. …
Nkarta, Inc. (NKTX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. See Nkarta, Inc. (NKTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Oct 2, 2023 · NKTX Stock Predictions, Articles, and Nkarta Inc News ... NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program. Analyst projections state that NKTX is forecast to be at a low of $10.00 and a high of $25.00. In order for the stock price to hit the forecast high, the stock would need to plunge -972.96% from its current level, while the stock would need to crash -329.18% from its current level to reach the projected low. Nkarta Inc (NKTX) estimates and ...NkartaInc overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please ...Find the latest Zymeworks Inc. (ZYME) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...
Nkarta Stock Forecast, "NKTX" Share Price Prediction Charts Is "Nkarta Inc" a Good Investment? Current price today: 2.675 USD (+0.753%) History Forecast Data Market …
Nkarta, Inc. (NKTX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. See Nkarta, Inc. (NKTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Get Opthea Ltd (OPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC ... NKTX. Nkarta Inc. 2.72, +0.08, +3.03%. GALT. Galectin ...Jun 2, 2023 · Analyst Price Forecast Suggests 852.85% Upside As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60. Oct. 17, 2023, 07:24 AM. (RTTNews) - Biopharmaceutical company Nkarta, Inc. (NKTX) announced Tuesday the clearance of an Investigational New Drug (IND) application by the U.S. Food and Drug ...Nkarta (NKTX) Company Description: Nkarta Inc is a bio-pharmaceutical company focused on the discovery, development and commercialization of engineered, allogeneic, and off-the-shelf cell ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for IO Biotech Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 7.00.Analysts are generally bullish on Nkarta’s long-term prospects, but they are divided on how high the stock price could go in 2023. Some analysts believe that the stock could reach $20 or even $30 per share, while others believe that it is more likely to trade in the $10-$15 range. Ultimately, how high NKTX will go in 2023 is a matter of ...
Nkarta, Inc. NKTXNASDAQ NKTXNASDAQ 2.72USD +0.08 +3.03% At close at 15:50 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast Price target …NKTX Earnings Forecast. Next quarter’s earnings estimate for NKTX is -$0.59 with a range of -$0.96 to -$0.40. The previous quarter’s EPS was -$0.52. NKTX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.59% of the time in the same period. Find the latest Gritstone bio, Inc. (GRTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Oct 2, 2023 · Since the start of the year, NKTX lost 77% of its equity value. However, in sharp contrast to the market performance, analysts rate NKTX a unanimous strong buy. Their average price target lands at ... The average Pinterest stock price prediction forecasts a potential upside of 1.4% from the current PINS share price of $34.07. What is PINS's forecast return on equity (ROE) for 2023-2026? (NYSE: PINS) forecast ROE is N/A, which is considered weak.At the time of writing, Nkarta Inc [NKTX] stock is trading at $1.57, up 13.77%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The NKTX shares have gain 14.60% over the last week, with a monthly amount drifted -8.19%, and not seem to beMar 20, 2023 · SVB Securities analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) today.The company’s shares opened today at $3.76. According to TipRanks, Graybosch is an ...
View the latest NKTX earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. QQQ 386.32 (-0.93%) AAPL 189.43 (-0.95%) MSFT 369.14 (-1.43%) ... Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for IO Biotech Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 7.00.
A high-level overview of Nkarta, Inc. (NKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Based on 10 Wall Street analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $25.30 with a high forecast of $35.00 and a low forecast of $19.00. The average price target represents a 84.00% change from the last price of $13.75. Highest Price Target $35.00. Average Price Target $25.30.We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing their ability to search and destroy tumor cells. Learn More.Nkarta, Inc. Stock Earnings. The value each NKTX share was expected to gain vs. the value that each NKTX share actually gained. Nkarta, Inc. ( NKTX) reported Q3 2023 earnings per share (EPS) of -$0.52, beating estimates of -$0.67 by 22.07%. In the same quarter last year, Nkarta, Inc. 's earnings per share (EPS) was -$0.58.Nkarta (NKTX) is a clinical-stage biopharmaceutical company that develops and commercializes cell therapies for cancer treatment. The company's co-lead product candidates are NKX101 and NKX019, which are in phase I trials for various B cell malignancies. Analysts have a consensus rating of Buy and a price target of $15.67, up 671.8% from its current price of $2.03.Analysts are generally bullish on Nkarta’s long-term prospects, but they are divided on how high the stock price could go in 2023. Some analysts believe that the stock could reach $20 or even $30 per share, while others believe that it is more likely to trade in the $10-$15 range. Ultimately, how high NKTX will go in 2023 is a matter of ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Seven Arts Entertainment share forecasts, stock quote and buy / sell signals below. According to present data Seven Arts Entertainment's SAPX shares and potentially its market environment have been in bearish cycle last 12 months (if exists).We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...
Nkarta Inc [NKTX] stock prices are up 6.02% to $2.64 at the moment. It is a good measure of the stock's recent performance to check whether the stock's short-term value is rising or falling. The NKTX shares have gain 1.93% over the last week, with a monthly amount glided 30.05%, and seem to be holding
US$296.82m. Market Cap. US$128.57m. NKTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. n/a. Enterprise Value/EBITDA.
Analyst Forecast According to 6 analysts, the average rating for NKTX stock is "Strong Buy." The 12-month stock price forecast is $13.0, which is an increase of …Nkarta's earnings are forecast to decline at 9.2% per annum while its annual revenue is expected to grow at 77.8% per year. EPS is expected to grow by 7.3% per annum.CRISPR Therapeutics (NASDAQ: CRSP) and Nkarta (NASDAQ: NKTX) aim to develop CRISPR/Cas9 gene-edited cell therapies for cancer. Under a new collaboration, the two companies will develop and ...A high-level overview of Nkarta, Inc. (NKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.If you're new to stock investing, here's how to buy Exela Technologies stock. What is XELA's forecast return on assets (ROA) for 2023-2023? (NASDAQ: XELA) forecast ROA is -98.28%, which is lower than the forecast US Software - …In December 2022, Nkarta had US$352m in cash, and was debt-free. Looking at the last year, the company burnt through US$104m. So it had a cash runway of about 3.4 years from December 2022. There's ...2023-01-17. 3,691. $5.49. $20.26k Sell. 1 of 2. NKTX insiders have sold more... subscribe to Premium to read more. Net Insider Buy/Sell (L12M) Ownership. Be the first to know when NKTX insiders and whales buy or sell their stock. Get Free NKTX Updates.Nov 30, 2023 · A high-level overview of Nkarta, Inc. (NKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Mar. 20, 2023, 08:47 AM. SVB Securities analyst Daina Graybosch maintained a Buy rating on Nkarta ( NKTX – Research Report) today. The company’s shares opened today at $3.76. According to ...Mar 20, 2023 · SVB Securities analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) today.The company’s shares opened today at $3.76. According to TipRanks, Graybosch is an ... Stock Price Forecast The 12 analysts offering 12-month price forecasts for C3.ai Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 14.00.Instagram:https://instagram. xomo dividendwhat is the dollar indexmgv etfag stocks Jun 15, 2023 · (See NKTX stock forecast) To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Penny Stock Screener. Disclaimer: The opinions expressed in this article are ... trading courses for beginnersbest reits stocks Nkarta, Inc. Stock Earnings. The value each NKTX share was expected to gain vs. the value that each NKTX share actually gained. Nkarta, Inc. ( NKTX) reported Q3 2023 earnings per share (EPS) of -$0.52, beating estimates of -$0.67 by 22.07%. In the same quarter last year, Nkarta, Inc. 's earnings per share (EPS) was -$0.58. kingdom holding company Stock Price Forecast The 12 analysts offering 12-month price forecasts for C3.ai Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 14.00.Forecast. NKTX technical analysis. This gauge displays a real-time technical ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ...